Narayana Hrudayalaya Q2 FY26 earnings call: Revenue & Margins
Q2 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹1,644Cr
- +20.3% YoY
- +9.1% QoQ
- Net profit
- ₹258Cr
- +29.6% YoY
- +31% QoQ
- Margin
- 24%
- +1 pp YoY
- +2 pp QoQ
Guidance rank: #27 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Hospital patient flow in new hospitals is still establishing; initially, high minimum guarantees cause higher professional fees as a percentage of revenue, but this is expected to moderate over time, aligning with peers. EBITDA growth driven by volume pick-up through better payor-mix with more high-paying payors, not just pricing increases (low single-digit pricing hikes annually).
From Narayana Hrudayalaya Ltd's Q2 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Hospital patient flow in new hospitals is still establishing; initially, high minimum guarantees cause higher professional fees as a percentage of revenue, but this is expected to moderate over time, aligning with peers. (Page 25)
- Volumes are currently stabilizing; from next two quarters onwards, positive volume growth alongside improved realizations due to better payor-mix is anticipated. (Page 15)
- Incremental revenue growth is attributed to better paying payors, efficiency improvements, throughput enhancement, and increase in high-order procedures rather than pricing hikes. (Page 25)
- Cayman hospital revenue saw significant growth post-commissioning of new hospital, with approximately 50% increase in discharges and outpatient/daycare volumes; further growth expected for a few more quarters before moderating to high single-digit growth. (Pages 4, 15)
- Insurance business growth in Cayman is early-stage with strong sales pipeline and increasing employer interest, but underwriting results will stabilize only over multiple quarters; room for considerable growth remains. (Pages 12, 15)
2 more points from Narayana Hrudayalaya Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Narayana Hrudayalaya Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Planned CapEx guidance for FY26 and FY27: Detailed guidance for FY27 will be provided closer to year-end.
- Over the next three years, a total of about INR 3,000 crores CapEx is planned in India, covering Greenfield, Brownfield, Operations & Maintenance, and acquisitions.
- Spend breakup and project status for individual hospitals are available in the investor slides.
- Some spillover of CapEx timing expected, with cash outflows possibly extending slightly beyond fiscal year boundaries.
- Investments include setting up new hospitals (e.g., 100-bed hospital in Bangalore expected by Q1 FY26).
2 more points from Narayana Hrudayalaya Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Narayana Hrudayalaya Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Narayana Hrudayalaya Ltd said on order book & pipeline — free account, 30 seconds.
Narayana Hrudayalaya Ltd — Quarterly revenue & net profit
Narayana Hrudayalaya Ltd Q2 FY26 results — key figures
| ₹ Cr | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 1,644 | 1,367 | +20.3% | 1,507 | +9.1% |
| Operating profit (EBITDA) | 401 | 309 | +29.8% | 337 | +19% |
| Operating margin | 24% | 23% | +1 pp | 22% | +2 pp |
| Profit before tax | 296 | 232 | +27.6% | 232 | +27.6% |
| Net profit (PAT) | 258 | 199 | +29.6% | 197 | +31% |
| EPS (₹) | 12.64 | 9.72 | +30% | 9.62 | +31.4% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.8K Cr, net profit ₹301 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Narayana Hrudaya's management said in earlier quarters
Others in Healthcare Services this season
- Maitreya Medicare (Q2 FY26)
23.92 crore (Page 26). Key investor presentation takeaways from Maitreya Medicare's Q2 FY26 investor presentation — and how it ranks against sector peers.
- Metropolis Healt (Q2 FY26)
Organic growth remains strong at around 12%, with no immediate price hikes planned. Key concall takeaways from Metropolis Healt's Q2 FY26 earnings call — and…
- 3B Blackbio (Q2 FY26)
Q2 FY 2025-26 sales: ₹3042.83 Lakh (including COVID sales ₹10.23 Lakh), up from ₹2457.55 Lakh in Q2 FY 2024-25. Key concall takeaways from 3B Blackbio DX Ltd's…
- Unihealth Hosp (Q2 FY26)
Nashik financial closure achieved via equity and bank debt (INR 22 crores from Bank of India). Key concall takeaways from Unihealth Hospitals Ltd's Q2 FY26…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Narayana Hrudayalaya Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Narayana Hrudayalaya Ltd Q2 FY26 results?
Hospital patient flow in new hospitals is still establishing; initially, high minimum guarantees cause higher professional fees as a percentage of revenue, but this is expected to moderate over time, aligning with peers. EBITDA growth driven by volume pick-up through better payor-mix with more high-paying payors, not just pricing increases (low single-digit pricing hikes annually).
What is Narayana Hrudayalaya Ltd share price analysis?
Narayana Hrudayalaya Ltd currently shows a neutral. The stock trades at a P/E of 45.1 with a market cap of ₹38,892 Cr. Investors should review the full earnings analysis for detailed insights.
Is Narayana Hrudayalaya Ltd planning capital expenditure?
Planned CapEx guidance for FY26 and FY27: Detailed guidance for FY27 will be provided closer to year-end.
Keep Narayana Hrudayalaya Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
